Clinical Research Directory
Browse clinical research sites, groups, and studies.
Photobiomodulation Therapy in the Management of Chemotherapy-Induced Peripheral Neuropathy
Sponsor: Jessa Hospital
Summary
This study aims to investigate the effectiveness of photobiomodulation therapy (PBM) in the management of chemotherapy-induced peripheral neuropathy (CIPN). Therefore, the hypothesis is that PBM can reduce the severity of CIPN in cancer patients, increasing the patient's quality of life.
Official title: Evaluating the Efficacy of Photobiomodulation Therapy in the Management of Chemotherapy-induced Peripheral Neuropathy: a Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
172
Start Date
2023-03-27
Completion Date
2030-03-15
Last Updated
2023-03-30
Healthy Volunteers
No
Interventions
Multiwave Locked System® (M6 laser, ASA srl, Arcugnano (VI), Italy)
MLS® Laser M6 is a PBM device that allows the patients to be treated in various positions, either sitting, lying down or at a distance, without risk of contamination. Treatment times are carefully calibrated to deliver the best possible energy dose to the tissue being treated.
Locations (1)
Jessa Hospital
Hasselt, Limburg, Belgium